![Table 1 from Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. | Semantic Scholar Table 1 from Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/67c0797707e78e220989e461b8072db79ed1fb0a/5-Table1-1.png)
Table 1 from Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. | Semantic Scholar
![Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction](https://www.kjim.org/upload/thumbnails/t4-kjim-2023-223.png)
Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction
![Frontiers | Effect of arotinolol on chronic heart failure: A systematic review and meta-analysis of randomized controlled trials Frontiers | Effect of arotinolol on chronic heart failure: A systematic review and meta-analysis of randomized controlled trials](https://www.frontiersin.org/files/Articles/1071387/fcvm-09-1071387-HTML-r1/image_m/fcvm-09-1071387-g005.jpg)
Frontiers | Effect of arotinolol on chronic heart failure: A systematic review and meta-analysis of randomized controlled trials
Switching to once-daily evidence-based [beta]-blockers in patients with systolic heart failure or left ventricular dysfunction after myocardial infarction - Document - Gale OneFile: Health and Medicine
![Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio](https://scielo.isciii.es/img/revistas/pharmacy/v7n4/205-212_03.gif)
Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio
![Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients | Hypertension Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients | Hypertension](https://www.ahajournals.org/cms/asset/c13cbce0-37c4-4dc9-9df5-f3a87c83682b/hypertensionaha.120.16402.fig05.jpg)
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients | Hypertension
![Table 1 from Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. | Semantic Scholar Table 1 from Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d74cb01d7491e0648e608b1b314629930ea1a050/3-Table1-1.png)
Table 1 from Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. | Semantic Scholar
![Dose Response Relationship of RAS Blocker and beta-Blocker in Patients with Acute Heart Failure Syndrome: Data from the Korean Acute Hart Failure (KorAHF) Registry - ScienceDirect Dose Response Relationship of RAS Blocker and beta-Blocker in Patients with Acute Heart Failure Syndrome: Data from the Korean Acute Hart Failure (KorAHF) Registry - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1071916419311868-gr14.jpg)
Dose Response Relationship of RAS Blocker and beta-Blocker in Patients with Acute Heart Failure Syndrome: Data from the Korean Acute Hart Failure (KorAHF) Registry - ScienceDirect
![Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockers. - Abstract - Europe PMC Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockers. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4175882/bin/IJPharm-46-485-g004.jpg)